Predicting human hepatic clearance and DDI effects from in vitro metabolism and transport data
|
|
- Malcolm Fitzgerald
- 6 years ago
- Views:
Transcription
1 Predicting uman epatic clearance and DDI effects from in vitro abolism and transport data Kenici Umeara, Birk Poller, Annett Kunze and Gian Camenisc Novartis Parma AG, DMPK DDI-2015, International Conference on Drug-Drug Interactions June 30, 2015 Objectives Demonstrate te role of transporters in epatic elimination and epatic clearance prediction Different liver clearance models (istory) Advanced IVIVE odology incl. transporters (extended clearance model) Estimate contribution of epatic transporter(s) to Drug-Drug Interaction (DDI) potential as victim drug(s) Static and dynamic approaces Propose te extended clearance classification od to facilitate/optimize Drug Development process 2 DDI-2015 Kenici Umeara June 30,
2 Assumptions and Limitations is assumed to be te major (only) elimination patway were DDI can occur Well-stirred model CL = Q E Q f = Q + f Only unbound (free) concentration is subject to epatic elimination Inibition type for evaluating DDI potential: competitive u,b u,b CL int CL int 3 DDI-2015 Kenici Umeara June 30, 2015 Basic Clearance Models f u,b Q CL int CL int = CL or CL int = inf abolism is rate-limiting clearance process epatocyte uptake (influx) is ratelimiting clearance process (Iwatsubo et al., 1997) (Watanabe et al., 2010) 4 DDI-2015 Kenici Umeara June 30,
3 Predicting Clearance R 2 =0.781 Rat clearance prediction wit: CLint = CL Under-predictive mainly for class 3 and 4 compounds Classes of uptake transporter substrates! Rat clearance prediction wit: CLint = CLinf Over-predictive mainly for (low-medium clearance) class 2 and 4 compounds R 2 =0.679 Classes of efflux transporter substrates! Transporters are indeed playing a significant role 5 DDI-2015 Kenici Umeara June 30, 2015 Hepatic Mecanistic Clearance Model f u,b Q inf CL Blood eff CL CL int,all CL int,all = inf eff (CL + (CL ) ( = ) ( inf,act eff,act + + inf,pas eff,pas ) (CL ) + (CL ) ) Sirianni and Pang, 1997 Sitara et al., DDI-2015 Kenici Umeara June 30,
4 Hepatic clearance mecanisms Wat in vitro assays are available? + inf, act inf,pas CL CL + eff,act eff,pas (Niemi et al., 2011) Mecanism: In vitro assay: Active processes: Factors to consider: Influx (uptake) Suspended epatocyte SLC transporters inf,pas Metabolism microsomes, S9 (Pase I) enzymes fu,mic Biliary retion Sandwic-cultured epatocytes ABC transporters fu,ep, abolism Efflux (back-flux) Overall clearance in sandwic-cultured epatocytes ABC (SLC) transporters Differential approac or eff = inf,pas (Umeara and Camenisc, 2012) 7 DDI-2015 Kenici Umeara June 30, 2015 Predicting Clearance R 2 =0.781 Rat clearance prediction wit CLint = CLint,all R 2 =0.928 R 2 =0.928 CLint = CL R 2 =0.679 CLint = CLinf 8 DDI-2015 Kenici Umeara June 30,
5 Interim Conclusions (1) Te new extended clearance model is valid Main reason for basic models not being predictive are indeed transporter-related clearance processes Neverteless, basic models are predictive for some compounds wereas tey are under-/over-predictive for oters 9 DDI-2015 Kenici Umeara June 30, 2015 Static DDI prediction as a Victim Drug in 1 inf, act 1+ pv/ inf Inibition 1 CL 1+ Inibition Inibition 1 inf, 1+ Extended epatic organ model: f u,b Q inf,i CL,i CL Blood CL, int, alli eff, i Inibition 1 eff, act 1+ eff CL int, all, i ( = ( inf, act eff, act = inf, i eff, i ( CL + ( CL, i, i, i pv/ inf) + eff) + ), i ) inf, pas eff, pas ) ( CL ) + ( CL ) ) )) )) 10 DDI-2015 Kenici Umeara June 30,
6 Static Worst-case DDI prediction - Atorvastatin Atorvastatin: mainly eliminated from liver, a substrate of epatic uptake transporters OATP1B1 and oxidative enzyme CYP3A Predicted AUC ratio Predicted AUC ratio inf,c inibition (%) CL inibition (%) 11 DDI-2015 Kenici Umeara June 30, 2015 Static prediction on te epatic uptake clearance (1) RAF and REF concepts (Kunze et al., 2014) 12 DDI-2015 Kenici Umeara June 30,
7 Static prediction on te epatic uptake clearance (2) OATP1B1 and OATP1B3-mediated uptake of statins ato: atorvastatin, cer: cerivastatin, flu: fluvastatin, lov: lovastatin, pit: pitavastatin, pra: pravastatin, ros: rosuvastatin, sim: simvastatin (Kunze et al., 2014) 13 DDI-2015 Kenici Umeara June 30, 2015 Dynamic DDI prediction as a Victim Drug in Victim drug (transporter substrates as e.g. atorvastatin): Perpetrator drug: Periperal Q Xp k21 k12 Central Cb, V1 Periperal Q Xpi k21i k12i Central Cbi, V1i CLr CLoters Inibition CLr(i) CLoters(i ) p.o. (1 st order absorption) Dose kafafg exp(-ka t) inf CL Blood Q C1, V1 eff C2, V2 CL Inibition Ci, V1+V2 CL(i) CL(i) Q p.o. (1 st order absorption) Dosei kaifaifgi exp(-kai t) Modification of a model proposed in (Watanabe et al., 2009) 14 DDI-2015 Kenici Umeara June 30,
8 Dynamic Worst-case DDI prediction - Atorvastatin Influx Metabolism Influx+ abolism Plasma Atorvastatin plasma concentration (ng/ml) Rinf=1.0 (control) Rinf=3.0 Rinf=1 inf, c=0 Atorvastatin plasma concentration (ng/ml) R=1.0 (control) R=3.0 R=1 Atorvastatin plasma concentration (ng/ml) Control inf,c=0 and R= Time () Time () Time () Atorvastatin liver concentration (ng/g liver) Rinf=1.0 (control) Rinf=3.0 Rinf=1 inf,c=0 Atorvastatin liver concentration (ng/g liver) R=1.0 (control) R=3.0 R=1 Atorvastatin liver concentration (ng/g liver) Control inf,c=0 and R= Time () 15 DDI-2015 Kenici Umeara June 30, Time () Dose: 40 mg p.o., single dose (PBPK model was validated to compare wit clinical observations) R (competitive inibition factor)=1, 3 and Time () Static vs. Dynamic DDI prediction - Atorvastatin Influx: inf,c = 0 Hepatic process inibited: worst case Metabolism: R = 10 Influx+abolism: inf,c=0 and R=10 Model Static Dynamic Static Dynamic Static Dynamic AUCratio (plasma) AUCratio (liver) ND 0.6 ND 1.1 ND 0.6 ND: not determined All values are expressed as relative canges compared to control values witout any DDI effects. Static DDI prediction results: Camenisc and Umeara, DDI-2015 Kenici Umeara June 30,
9 Interim Conclusions (2) For te static DDI potential prediction of victim drugs were te epatic uptake is te rate-determining step, RAF and REF concepts provide useful information on te contribution ratio of te uptake transporters Te effects of clearance process inibition on exposure of victim drug(s) migt be differently estimated between static and dynamic predictions, indicating importance of dynamic modeling approac Te IVIVE approac followed by DDI potential prediction using static and dynamic models is working but very work intensive i.e. cannot be used as a standard procedure Wit elp of compound/clearance classification system, te drug development strategy can be facilitated and optimized (e.g. BDDCS: CL works for class 1 and class 2 compounds, wereas inf works for classes 1 and 3) 17 DDI-2015 Kenici Umeara June 30, 2015 BDDCS Solubility D/250 ml Solubility < D/250 ml Metabolism 70% Hig solubility Extensive abolism Transporter effects minimal Class 1 Class 2 Low solubility Extensive abolism Efflux transporter effects can occur Metabolism < 70% Hig solubility Poor abolism Uptake transporter effects predominant (may be modulated by efflux transporters) Class 3 Class 4 Low solubility Poor abolism Uptake and efflux transporter effects may be important (Wu and Benet, 2005) 18 DDI-2015 Kenici Umeara June 30,
10 Extended Model vs BDDCS Metabolism is major epatic elimination patway Metabolism 70% Metabolism < 70% eff inf = pas Solubility D/250 ml Hig solubility Extensive abolism Transporter effects minimal Hig solubility Poor abolism Uptake transporter effects predominant (may be modulated by efflux transporters) Class 3 Class 1 eff << CL pas eff eff >> CL CL ( CL+ CL) inf + ( CL inf eff inf ( CL+ CL) ) Class 2 Class 4 Soluility < D/250 ml Low solubility Extensive abolism Efflux transporter effects can occur Low solubility Poor abolism Uptake and efflux transporter effects may be important Drug transport and abolism may contribute to epatic elimination 19 DDI-2015 Kenici Umeara June 30, 2015 Compound-(sub)Class Dependent Drug Development Key information from extended model: If inf eff pas compound is a class 1 or 2 compound Well-stirred liver model: igly permeable if CLint,all = pas >> Q (i.e. > 3-times Q) BDDCS (in vivo observationbased) Wu and Benet, 2005 ID-ECCCM (in vitro data-based extended clearance concept classification od) Camenisc and Umeara, 2012 Camenisc et al., 2015 Propranolol Quinidine Verapamil CsA Ketoconazole Atorvastatin - Propranolol Quinidine Verapamil Ketoconazole CL predictive for epatic elimination Metabolism-based DDI Aliskiren Pravastatin Valsartan Ciidine Digoxin Furosemide Ciprofloxacin Ciidine Ciprofloxacin CsA Atorvastatin Digoxin Furosemide Aliskiren Pravastatin Valsartan CL not predictive for epatic elimination Metabolism- and transporter-based DDI 20 DDI-2015 Kenici Umeara June 30,
11 Final Conclusions Wit elp of above relationsips compounds can be assigned to (sub)classes according to te in vitro data-based extended clearance concept classification od (ECCCM) Correct ECCCM class assignment is te prerequisite for a compounddependent, tailor-made pre-clinical and clinical follow-up program in Drug Development. e.g. knowing te ECCCM compound (sub)classes allows a compound-class dependent static and dynamic prediction of te DDI potential of drug substances Te igly predictive clearance estimates based on te extended organ model can be used for te elaboration of more complex and predictive PK/PD models, after confirming te ECCCM class 3 and 4 assignment 21 DDI-2015 Kenici Umeara June 30,
The general concept of pharmacokinetics
The general concept of pharmacokinetics Hartmut Derendorf, PhD University of Florida Pharmacokinetics the time course of drug and metabolite concentrations in the body Pharmacokinetics helps to optimize
More informationNa Li, PhD. Application of a Fluorescent Substrate / Inside-Out Transporter Vesicle Assay for Identifying Inhibitors of MRP Transport
Application of a Fluorescent Substrate / Inside-Out Transporter Vesicle Assay for Identifying Inhibitors of MRP Transport Na Li, PhD BD Biosciences October 20, 2010 BD Gentest Transporter Seminar Series
More informationABC Transporter Vesicle Assay: Comparison of Cold (LC-MS/MS) and Hot (Radiolabeled) Methods. Na Li, PhD. BD Biosciences Discovery Labware May 29, 2012
ABC Transporter Vesicle Assay: Comparison of Cold (LC-MS/MS) and Hot (Radiolabeled) Methods Na Li, PhD BD Biosciences Discovery Labware May 29, 212 Today s Topics Overview of the important role of ABC
More informationIn Vitro Transporter Testing Alignment with Regulatory Agency Guidelines and ITC Recommendations. Elke S. Perloff, Ph.D.
In Vitro Transporter Testing Alignment with Regulatory Agency Guidelines and ITC Recommendations Elke S. Perloff, Ph.D. BD Biosciences February 23, 2011 Presentation Overview Guidance documents and position
More informationPhysical-Chemistry Factors Affecting Oral Absorption. Objectives. ph - Partition Theory. 27 September Chapter 23 1
Physical-Chemistry Factors Affecting Oral Absorption Objectives Understand the physical-chemical factors that affect oral absorption Understand the ph-partition hypothesis as it applies to drug absorption
More informationExponential Decay CHEM 1231 Fall 2009 Claudia Neuhauser
Exponential Decay Propylene glycol monometyl eter (PGME) is a solvent used in surface coatings or cleaners. A study by Domoradzki et al. 003 examined ow quickly PGEM was eliminated from blood in vitro.
More informationValidation of the GastroPlus TM Software Tool and Applications
Validation of the GastroPlus TM Software Tool and Applications Fagen Zhang and Leah Luna The Dow Chemical Company FZ/MB 01.11.11 Acknowledgements Michael Bartels Barun Bhhatarai (Novartis) Tyler Auernhammer
More informationPHA 4123 First Exam Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.
PHA 4123 First Exam Fall 1998 On my honor, I have neither given nor received unauthorized aid in doing this assignment. TYPED KEY Name Question 1. / pts 2. /2 pts 3. / pts 4. / pts. / pts 6. /10 pts 7.
More informationMechanisms of Drug Action Lecture #1 9/7/05
20.201 Mechanisms of Drug Action Lecture #1 9/7/05 Instructors Prof. Peter Dedon Prof. Steven Tannenbaum Monday and Wednesday 1:30-3:00 pm Recitations on Friday 1:30-2:30 pm 1 Course bjectives Develop
More informationPrediction of Oral Absorption: 6-Fluoroquinolones
Prediction of ral Absorption: 6-luoroquinolones Mª del Val Bermejo Sanz, Ph.D. Depto. armacia y Tecnología armacéutica acultad de armacia. Universidad de Valencia Valencia, España Strategies for ral Drug
More informationNonlinear pharmacokinetics
5 Nonlinear pharmacokinetics 5 Introduction 33 5 Capacity-limited metabolism 35 53 Estimation of Michaelis Menten parameters(v max andk m ) 37 55 Time to reach a given fraction of steady state 56 Example:
More informationGI Simulation Methods
Gastrointestinal Simulation Based on the Advanced Compartmental Absorption and Transit (ACAT) Michael B. Bolger, Ph.D. Founding Scientist Simulations Plus, Inc. GI Simulation Methods Dispersion Model Ho,
More informationHandling parameter constraints in complex/mechanistic population pharmacokinetic models
Handling parameter constraints in complex/mechanistic population pharmacokinetic models An application of the multivariate logistic-normal distribution Nikolaos Tsamandouras Centre for Applied Pharmacokinetic
More informationCTP-656 Tablet Confirmed Superiority Of Pharmacokinetic Profile Relative To Kalydeco in Phase I Clinical Studies
Tablet Confirmed Superiority Of Pharmacokinetic Profile Relative To Kalydeco in Phase I Clinical Studies 39 th European Cystic Fibrosis Conference 8-11 June 2016, Basel, Switzerland 2014 Concert Pharmaceuticals,
More informationOrgan-on-a-chip: practical applications & challenges. Remko van Vught
Organ-on-a-chip: practical applications & challenges Remko van Vught 10-4-2018 A leap forward in physiological relevance The challenge of reductionism: Make things as simple as possible, but not simpler,
More informationHomework 1 (PHA 5127)
Homework 1 (PHA 5127) 1. The elimination rate constant of a drug is 1 hr -1 : k e =1 hr -1 A. Half-life: t 1/2 = ln(2)/k e = 0.693/1 hr -1 = 0.693 hr B. C 1 =5ng/ml First-order elimination: k e = (ln(c
More informationPhotochemical synthesis of 3-azabicyclo[3.2.0]heptanes: advanced building blocks for drug discovery
Photochemical synthesis of 3-azabicyclo[3.2.0]heptanes: advanced building blocks for drug discovery Aleksandr V. Denisenko, a,b Tetiana Druzhenko, c Yevhen Skalenko, a Maryna Samoilenko, b Oleksandr O.
More informationADMET property estimation, oral bioavailability predictions, SAR elucidation, & QSAR model building software www.simulations-plus.com +1-661-723-7723 What is? is an advanced computer program that enables
More informationDRUG DRUG INTERACTION PREDICTION ASSESSMENT
Journal of Biopharmaceutical Statistics, 19: 641 657, 2009 Copyright Taylor & Francis Group, LLC ISSN: 1054-3406 print/1520-5711 online DOI: 10.1080/10543400902964084 DRUG DRUG INTERACTION PREDICTION ASSESSMENT
More informationIn Vivo Predictive Dissolution Flux Measurements. Konstantin Tsinman, PhD Chief Scientific Officer Pion Inc
In Vivo Predictive Dissolution Flux Measurements Konstantin Tsinman, PhD Chief Scientific Officer Pion Inc ktsinman@pion-inc.com What do we mean by IVIVC? USP 1 : The establishment of a rational relationship
More informationGenetically Modified Human Renal Proximal Tubule Epithelial Cells (RPTEC/TERT1) A New Model for Drug Toxicity Studies
Genetically Modified Human Renal Proximal Tubule Epithelial Cells (RPTEC/TERT1) A New Model for Drug Toxicity Studies Chaozhong Zou, Ph.D. Senior Scientist, ATCC About ATCC Founded in 1925, ATCC is a non-profit
More informationMulticompartment Pharmacokinetic Models. Objectives. Multicompartment Models. 26 July Chapter 30 1
Multicompartment Pharmacokinetic Models Objectives To draw schemes and write differential equations for multicompartment models To recognize and use integrated equations to calculate dosage regimens To
More informationTime (hours) Morphine sulfate (mg)
Mat Xa Fall 2002 Review Notes Limits and Definition of Derivative Important Information: 1 According to te most recent information from te Registrar, te Xa final exam will be eld from 9:15 am to 12:15
More information10.1 VIBRATIONAL RELAXATION *
Andrei Tokmakoff, MIT Department of Cemistry, 3//009 p. 0-0. VIRATIONAL RELAXATION * Here we want to address ow a quantum mecanical vibration undergoes irreversible energy dissipation as a result of interactions
More informationDesalination by vacuum membrane distillation: sensitivity analysis
Separation and Purification Tecnology 33 (2003) 75/87 www.elsevier.com/locate/seppur Desalination by vacuum membrane distillation: sensitivity analysis Fawzi Banat *, Fami Abu Al-Rub, Kalid Bani-Melem
More informationDetermination of Design Space for Oral Pharmaceutical Drugs
Determination of Design Space for Oral Pharmaceutical Drugs Kalliopi Chatzizaharia and Dimitris Hatziavramidis School of Chemical Engineering National Technical University of Athens, Greece Design Space
More informationDerivatives and Rates of Change
Section.1 Derivatives and Rates of Cange 2016 Kiryl Tsiscanka Derivatives and Rates of Cange Measuring te Rate of Increase of Blood Alcool Concentration Biomedical scientists ave studied te cemical and
More informationPHARMACOKINETIC DERIVATION OF RATES AND ORDERS OF REACTIONS IN MULTI- COMPARTMENT MODEL USING MATLAB
IJPSR (2016), Vol. 7, Issue 11 (Research Article) Received on 29 May, 2016; received in revised form, 07 July, 2016; accepted, 27 July, 2016; published 01 November, 2016 PHARMACOKINETIC DERIVATION OF RATES
More informationAt-a-Glance. Verapamil C 27 H 38 N 2 O 4 M+H + =
Application ote #LC-MS 80 Simultaneous Quantitative and Qualitative Measurements in a Single Workflow to Increase Productivity in Primary Drug Metabolism Investigations At-a-Glance n Increased productivity
More informationIntroduction to Pharmacokinetic Modelling Rationale
Introduction to Pharmacokinetic Modelling Rationale Michael Weiss michael.weiss@medizin.uni-halle.de Martin Luther University Halle-Wittenberg Philippus von Hohenheim, known as Paracelsus (1493-1541) Everything
More informationNonlinear Elimination of Drugs in One-Compartment Pharmacokinetic Models: Nonstandard Finite Difference Approach for Various Routes of Administration
Matematical and Computational Applications Article Nonlinear Elimination of Drugs in One-Compartment Parmacokinetic Models: Nonstandard Finite Difference Approac for Various Routes of Administration Oluwaseun
More informationLow Decibel Linear Way E
U.S. PATNTD Low Decibel Linear Way LWQLWTQLWSQ Low Decibel Linear Way series Sape lange type mounted from bottom Low Decibel Linear Way is a linear motion rolling guide for smoot and quiet motion. Its
More informationMembrane transport 1. Summary
Membrane transport 1. Summary A. Simple diffusion 1) Diffusion by electrochemical gradient no energy required 2) No channel or carrier (or transporter protein) is needed B. Passive transport (= Facilitated
More informationImproving Experimental Efficiency for Drug Metabolite Profiling and Identification
Improving Experimental Efficiency for Drug Metabolite Profiling and Identification Pengxiang Yang 1, Josef Ruzicka 1, Jessica Wang 1, Kate Comstock 1, Caroline Ding 1, Mark Sanders 1, and Michael Cameron
More informationADME SCREENING OF NOVEL 1,4-DIHYDROPYRIDINE DERIVATIVES
ITERATIAL JURAL F RESEARC I PARMACY AD CEMISTRY Available online at www.ijrpc.com Research Article ADME SCREEIG F VEL 1,4-DIYDRPYRIDIE DERIVATIVES A. Asma samaunnisa 1*, CS. Venkataramana 1 and V Madhavan
More informationNavigating the Transporter Wave of 2013: A Review of the Seven Recent ITC Publications on Drug Transporters
Navigating the Transporter Wave of 2013: A Review of the Seven Recent ITC Publications on Drug Transporters Greg Loewen, Andrea Wolff, Amanda Hays, Ph.D. XenoTech Drug Transport Group XenoTech brief introduction
More informationMATH CALCULUS I 2.1: Derivatives and Rates of Change
MATH 12002 - CALCULUS I 2.1: Derivatives and Rates of Cange Professor Donald L. Wite Department of Matematical Sciences Kent State University D.L. Wite (Kent State University) 1 / 1 Introduction Our main
More informationPopulation Pharmacokinetics in Support of Analgesics and Anaesthetics Studies in
Pyry Välitalo Population Pharmacokinetics in Support of Analgesics and Anaesthetics Studies in Special Populations Publications of the University of Eastern Finland Dissertations in Health Sciences 7.4
More informationSolve exponential equations in one variable using a variety of strategies. LEARN ABOUT the Math. What is the half-life of radon?
8.5 Solving Exponential Equations GOAL Solve exponential equations in one variable using a variety of strategies. LEARN ABOUT te Mat All radioactive substances decrease in mass over time. Jamie works in
More informationTargeted Covalent Inhibitors: A Risk-Benefit Perspective
Targeted Covalent Inhibitors: A Risk-Benefit Perspective 2014 AAPS Annual Meeting and Exposition San Diego, CA, November 4, 2014 Thomas A. Baillie School of Pharmacy University of Washington Seattle, WA
More informationReaction Rate (Kinetics) Reaction Rate
Instructor: Allan Felsot afelsot@tricity.wsu.edu Fall 2 Reaction Rate (Kinetics) ES/RP 3 Fundamentals of Environmental Toxicology Lecture / Pharmacokinetics (Toxicokinetics) & Pharmacodynamics (Toxicodynamics)
More informationBile salt transport profiling of hepatic transporters. Peter Krajcsi
Bile salt transport profiling of hepatic transporters Peter Krajcsi The human bile Carey and Duane: The liver, 3rd edition Bile acids / salts Cholesterol Hepatocytes Primary bile acids: Chenodeoxycholic
More informationMeasurement of Metabolic Stability Using SIM and Identification of Metabolites by Data Dependent Full-Scan MS/MS and CNL Scanning
Application Note: 349 Measurement of Metabolic Stability Using SIM and Identification of Metabolites by Data Dependent Full-Scan MS/MS and CNL Scanning Peter B Ehmer, Ethirajulu Kantharaj, Katie De Wagter,
More informationCYP Time Dependent Inhibition Atypical Kinetics. Ken Korzekwa Temple University School of Pharmacy and Kinetics & Simulation, LLC
CYP Time Dependent Inhibition Atypical Kinetics Ken Korzekwa Temple University School of Pharmacy and Kinetics & Simulation, LLC Acknowledgements TUSP Swati Nagar Jaydeep Yadav Pharma - Donald Tweedie
More information1 The concept of limits (p.217 p.229, p.242 p.249, p.255 p.256) 1.1 Limits Consider the function determined by the formula 3. x since at this point
MA00 Capter 6 Calculus and Basic Linear Algebra I Limits, Continuity and Differentiability Te concept of its (p.7 p.9, p.4 p.49, p.55 p.56). Limits Consider te function determined by te formula f Note
More informationCOMPUTER AIDED DRUG DESIGN (CADD) AND DEVELOPMENT METHODS
COMPUTER AIDED DRUG DESIGN (CADD) AND DEVELOPMENT METHODS DRUG DEVELOPMENT Drug development is a challenging path Today, the causes of many diseases (rheumatoid arthritis, cancer, mental diseases, etc.)
More informationCypExpress 3A4 Catalyzed Conversion of Testosterone (TE) to 6β- Hydroxytestosterone (HT)
TM CASE STUDY CypExpress 3A4 Catalyzed Conversion of Testosterone (TE) to 6β- Hydroxytestosterone (HT) Shuvendu Das, 1 Enrique Martinez, 2 and Mani Subramanian 1 1 Center for Biocatalysis and Bioprocessing,
More information770-9P. Sensitivity and Selectivity - A Case Study of LC/MS Enantioselective Resolution of Bupivacaine Using Vancomycin as a Chiral Stationary Phase
77-9P Sensitivity and Selectivity - A Case Study of LC/MS Enantioselective Resolution of Bupivacaine Using Vancomycin as a Chiral Stationary Phase J.T. Lee 1 Maria Esther Rodriguez Rosas 2 and Thomas E.
More informationMath Module Preliminary Test Solutions
SSEA Summer 207 Mat Module Preliminar Test Solutions. [3 points] Find all values of tat satisf =. Solution: = ( ) = ( ) = ( ) =. Tis means ( ) is positive. Tat is, 0, wic implies. 2. [6 points] Find all
More informationCSCE 478/878 Lecture 2: Concept Learning and the General-to-Specific Ordering
Outline Learning from eamples CSCE 78/878 Lecture : Concept Learning and te General-to-Specific Ordering Stepen D. Scott (Adapted from Tom Mitcell s slides) General-to-specific ordering over ypoteses Version
More informationGraviton Induced Nuclear Fission through Electromagnetic Wave Flux Phil Russell, * Jerry Montgomery
Graviton Induced Nuclear Fission troug Electromagnetic Wave Flux Pil Russell, * Jerry Montgomery Nort Carolina Central University, Duram, NC 27707 Willowstick Tecnologies LLC, Draper, UT 84020 (Dated:
More informationCEDIA CYCLOSPORINE PLUS (LOW RANGE) APPLICATION BECKMAN COULTER AU480 /AU680 /AU5800
CEDIA CYCLOSPORINE PLUS (LOW RANGE) APPLICATION BECKMAN COULTER AU480 /AU680 /AU5800 Beckman Coulter Reagent REF A31849 The CEDIA Cyclosporine PLUS assay is for the in vitro quantitative determination
More informationSECTION 3.2: DERIVATIVE FUNCTIONS and DIFFERENTIABILITY
(Section 3.2: Derivative Functions and Differentiability) 3.2.1 SECTION 3.2: DERIVATIVE FUNCTIONS and DIFFERENTIABILITY LEARNING OBJECTIVES Know, understand, and apply te Limit Definition of te Derivative
More informationThe Foundations of Chemistry 1
Te Foundations of Cemistry 1 1-1 (a) Biocemistry is te study of te cemistry of living tings. (b) Analytical cemistry studies te quantitative and qualitative composition analysis of substances. (c) Geocemistry
More informationChapter 2 Ising Model for Ferromagnetism
Capter Ising Model for Ferromagnetism Abstract Tis capter presents te Ising model for ferromagnetism, wic is a standard simple model of a pase transition. Using te approximation of mean-field teory, te
More informationRecall from our discussion of continuity in lecture a function is continuous at a point x = a if and only if
Computational Aspects of its. Keeping te simple simple. Recall by elementary functions we mean :Polynomials (including linear and quadratic equations) Eponentials Logaritms Trig Functions Rational Functions
More informationQuantum Mechanical Models of P450 Metabolism to Guide Optimization of Metabolic Stability
Quantum Mechanical Models of P450 Metabolism to Guide Optimization of Metabolic Stability Optibrium Webinar 2015, June 17 2015 Jonathan Tyzack, Matthew Segall, Peter Hunt Optibrium, StarDrop, Auto-Modeller
More informationFlow of information in a drug discovery pipeline. 7th lecture Modern Methods in Drug Discovery WS16/17 1
Flow of information in a drug discovery pipeline 7th lecture Modern Methods in Drug Discovery WS16/17 1 eadmet prediction early Absorption Distribution Metabolism Elimination Toxicology Pharmacokinetic
More informationUltrafast Analysis of Metabolic Stability Assays Using Agilent RapidFire High-resolution MS
Ultrafast Analysis of Metabolic Stability Assays Using Agilent RapidFire High-resolution MS Application Note Drug Discovery Authors Michelle V. Romm, Nikunj Parikh and Vaughn P. Miller Agilent Technologies
More informationACTIVE TRANSPORT AND GLUCOSE TRANSPORT. (Chapter 14 and 15, pp and pp )
ACTIVE TRANSPORT AND GLUCOSE TRANSPORT (Chapter 14 and 15, pp 140-143 and pp 146-151) Overview Active transport is the movement of molecules across a cell membrane in the direction against their concentration
More informationThe Laws of Thermodynamics
1 Te Laws of Termodynamics CLICKER QUESTIONS Question J.01 Description: Relating termodynamic processes to PV curves: isobar. Question A quantity of ideal gas undergoes a termodynamic process. Wic curve
More informationPrinciples of Drug Design
Advanced Medicinal Chemistry II Principles of Drug Design Tentative Course Outline Instructors: Longqin Hu and John Kerrigan Direct questions and enquiries to the Course Coordinator: Longqin Hu I. Introduction
More informationHANDBOOK OF DRUG ANALYSIS
HANDBOOK OF DRUG ANALYSIS APPLICATIONS IN FORENSIC AND CLINICAL LABORATORIES Ray H. Liu Daniel E. Gadzala American Chemical Society Washington, DC Contents Dedication Foreword Preface About the Authors
More informationDigital Filter Structures
Digital Filter Structures Te convolution sum description of an LTI discrete-time system can, in principle, be used to implement te system For an IIR finite-dimensional system tis approac is not practical
More informationChem 5 PAL Worksheet Acids and Bases Smith text Chapter 8
D.CHO3HE.KOHB.NHC.CHC3OHHCl3F.H.CHHCH3COG.H2HCHEM 5 PAL Worksheet Acids and Bases Fall 2017 Chem 5 PAL Worksheet Acids and Bases Smith text Chapter 8 Many substances in the body are acids and bases. Many
More informationMAT244 - Ordinary Di erential Equations - Summer 2016 Assignment 2 Due: July 20, 2016
MAT244 - Ordinary Di erential Equations - Summer 206 Assignment 2 Due: July 20, 206 Full Name: Student #: Last First Indicate wic Tutorial Section you attend by filling in te appropriate circle: Tut 0
More informationAlcohol dehydrogenase Assay Kit
Alcohol dehydrogenase Assay Kit Catalog Number KA3785 100 assays Version: 02 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 General
More informationTHE IDEA OF DIFFERENTIABILITY FOR FUNCTIONS OF SEVERAL VARIABLES Math 225
THE IDEA OF DIFFERENTIABILITY FOR FUNCTIONS OF SEVERAL VARIABLES Mat 225 As we ave seen, te definition of derivative for a Mat 111 function g : R R and for acurveγ : R E n are te same, except for interpretation:
More informationHuman papillomavirus,hpv ELISA Kit
Human papillomavirus,hpv ELISA Kit Catalog No: E0787h 96 Tests Operating instructions www.eiaab.com FOR RESEARCH USE ONLY; NOT FOR THERAPEUTIC OR DIAGNOSTIC APPLICATIONS! PLEASE READ THROUGH ENTIRE PROCEDURE
More informationRestricting brain penetration. transporters
Restricting brain penetration of fdrugs by targeting ti drug transporters Peter Bungay Pfizer Neusentis, Cambridge, UK RSC Drug Transporters Symposium: Target or Avoid? 13 th November 2014 1 introduction
More informationMetalloporphyrin. ~as efficient Lewis acid catalysts with a unique reaction-field~ and. ~Synthetic study toward complex metalloporphyrins~
Metalloporphyrin ~as efficient Lewis acid catalysts with a unique reaction-field~ and ~Synthetic study toward complex metalloporphyrins~ Literature Seminar Kenta Saito (D1) 1 Topics Chapter 1 ~as efficient
More informationNitric Oxide Assay Kit
Nitric Oxide Assay Kit Catalog Number KA1641 100 assays Version: 06 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Principle of the Assay... 3 General
More informationAntibiotic efflux pumps in eucaryotic cells: consequences for activity against intracellular bacteria
Antibiotic efflux pumps in eucaryotic cells: consequences for activity against intracellular bacteria Françoise Van Bambeke on behalf of J.M. Michot, C. Seral, M. Heremans, M.P. Mingeot-Leclercq, P.M.
More informationSite-Specific Prodrug Release Using Visible Light
Site-Specific Prodrug Release Using Visible Light Michael Y. Jiang and David Dolphin* J. Am. Chem. Soc., 2008, 130, 4236-4237 Li Zhang Current literature presentation 04-26-2008 Li Zhang @ Wipf Group Page
More informationModelling a complex input process in a population pharmacokinetic analysis: example of mavoglurant oral absorption in healthy subjects
Modelling a complex input process in a population pharmacokinetic analysis: example of mavoglurant oral absorption in healthy subjects Thierry Wendling Manchester Pharmacy School Novartis Institutes for
More informationHydrogen Peroxide Colorimetric Detection Kit
Hydrogen Peroxide Colorimetric Detection Kit Catalog Number KA1017 96 assays Version: 06 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Background... 3 Principle of the
More informationInfluence of Bacterial Growth Rate on Dose Optimization of Linezolid for Treatment of Tuberculosis
Influence of Bacterial Growth Rate on Dose Optimization of Linezolid for Treatment of Tuberculosis Kristina Bigelow Johns Hopkins University School of Medicine 1/15/217 Linezolid Recently added to WHOs
More informationHuman placenta lactogen, HPL ELISA kit
Human placenta lactogen, HPL ELISA kit Catalog No. E1442h (96 tests) Operating instruction www.eiaab.com FOR RESEARCH USE ONLY; NOT FOR THERAPEUTIC OR DIAGNOSTIC APPLICATIONS! PLEASE READ THROUGH ENTIRE
More informationPhysics 207 Lecture 23
ysics 07 Lecture ysics 07, Lecture 8, Dec. Agenda:. Finis, Start. Ideal gas at te molecular level, Internal Energy Molar Specific Heat ( = m c = n ) Ideal Molar Heat apacity (and U int = + W) onstant :
More informationProperties of the Spin-flip Amplitude of Hadron Elastic Scattering and Possible Polarization Effects at RHIC
Properties of te Spin-flip Amplitude of Hadron Elastic Scattering and Possible Polarization Effects at RHIC arxiv:ep-p/0210418v1 30 Oct 2002 O. V. Selyugin 1 Joint Institute for Nuclear Researc, Dubna,
More informationSupporting Information. A Quantitative Mechanistic PK/PD Model Directly Connects Btk Target Engagement and In Vivo Efficacy
Electronic Supplementary Material (ESI) for Chemical Science. This journal is The Royal Society of Chemistry 2017 Supporting Information A Quantitative Mechanistic PK/PD Model Directly Connects Btk Target
More informationFRAUNHOFER IME SCREENINGPORT
FRAUNHOFER IME SCREENINGPORT Design of screening projects General remarks Introduction Screening is done to identify new chemical substances against molecular mechanisms of a disease It is a question of
More informationBacterial Physiology Lec -3
Bacterial Physiology Lec -3 Uptake of nutrients by the cell The first step in nutrient use is uptake of the required nutrients by the microbial cell,uptake mechanism must be specific-that is the necessary
More informationOn drug transport after intravenous administration
On drug transport after intravenous administration S.Piekarski (1), M.Rewekant (2) Institute of Fundamental Technological Research Polish Academy of Sciences (1), Medical University of Warsaw, Poland Abstract
More informationIntroduction to Derivatives
Introduction to Derivatives 5-Minute Review: Instantaneous Rates and Tangent Slope Recall te analogy tat we developed earlier First we saw tat te secant slope of te line troug te two points (a, f (a))
More informationTK Solver Case Study: Pharmacokinetics
TK Solver Case Study: Pharmacokinetics The content for this example was provided by Professor Prasad Dhurjati of the University of Delaware. It is used there in the class Applied Mathematics for Chemical
More informationNoncompartmental vs. Compartmental Approaches to Pharmacokinetic Data Analysis Paolo Vicini, Ph.D. Pfizer Global Research and Development David M.
Noncompartmental vs. Compartmental Approaches to Pharmacokinetic Data Analysis Paolo Vicini, Ph.D. Pfizer Global Research and Development David M. Foster., Ph.D. University of Washington October 18, 2012
More informationQuantitative Pooling of Michaelis-Menten Equations in Models with Parallel Metabolite Formation Paths
Journal of Pharmacokinetics and Biopharmaceutics, Vol. 2, No. 2, I974 Quantitative Pooling of Michaelis-Menten Equations in Models with Parallel Metabolite Formation Paths Allen J. Sedman ~ and John G.
More informationCortisol (Horse) ELISA Kit
Cortisol (Horse) ELISA Kit Catalog Number KA2298 96 assays Version: 05 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Principle of the Assay... 3 General
More informationMODELING THE ABSORPTION, CIRCULATION, AND METABOLISM OF TIRAPAZAMINE
MODELING THE ABSORPTION, CIRCULATION, AND METABOLISM OF TIRAPAZAMINE Olivia Nguyen and Xiaoyu Shi Problem Statement: Tirapazamine (TPZ; 1,2,4-benzotriazin-3-amine 1,4-dioxide) is a hypoxia-activated prodrug
More informationMA119-A Applied Calculus for Business Fall Homework 4 Solutions Due 9/29/ :30AM
MA9-A Applied Calculus for Business 006 Fall Homework Solutions Due 9/9/006 0:0AM. #0 Find te it 5 0 + +.. #8 Find te it. #6 Find te it 5 0 + + = (0) 5 0 (0) + (0) + =.!! r + +. r s r + + = () + 0 () +
More informationImproving structural similarity based virtual screening using background knowledge
Girschick et al. Journal of Cheminformatics 2013, 5:50 RESEARCH ARTICLE Open Access Improving structural similarity based virtual screening using background knowledge Tobias Girschick 1, Lucia Puchbauer
More informationA physiological view and structures of mean residence times
Gen. Pysiol. Biopys. (2014), 33, 75 80 75 doi: 10.4149/gpb_2013060 A pysiological view and structures of mean residence times Mária Ďurišová Department of Parmacology of Inflammation, Institute of Experimental
More informationA Rapid Approach to the Confirmation of Drug Metabolites in Preclinical and Clinical Bioanalysis Studies
A Rapid Approach to the Confirmation of Drug Metabolites in Preclinical and Clinical Bioanalysis Studies APPLICATION BENEFITS Regulatory guidelines and recommendations place a greater emphasis on the detection
More informationArginase Assay Kit. Catalog Number KA assays Version: 05. Intended for research use only.
Arginase Assay Kit Catalog Number KA1609 200 assays Version: 05 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle of the Assay...
More informationD-Lactate Fluorometric/Colorimetric Assay Kit
D-Lactate Fluorometric/Colorimetric Assay Kit Catalog No. KM0096 Detection and Quantification of D-Lactate Concentrations in Biological Samples. Research Purposes Only. Not Intended for Diagnostic or Clinical
More informationIVIVC Industry Perspective with Illustrative Examples
IVIVC Industry Perspective with Illustrative Examples Presenter: Rong Li Pfizer Inc., Groton, CT rong.li@pfizer.com 86.686.944 IVIVC definition 1 Definition A predictive mathematical treatment describing
More informationPhase space in classical physics
Pase space in classical pysics Quantum mecanically, we can actually COU te number of microstates consistent wit a given macrostate, specified (for example) by te total energy. In general, eac microstate
More informationMetabolite Identification and Characterization by Mining Mass Spectrometry Data with SAS and Python
PharmaSUG 2018 - Paper AD34 Metabolite Identification and Characterization by Mining Mass Spectrometry Data with SAS and Python Kristen Cardinal, Colorado Springs, Colorado, United States Hao Sun, Sun
More informationDissociation from albumin: A potentially rate-limiting step in the
Proc. Nail. Acad. Sci. USA Vol. 82, pp. 1563-1567, March 1985 Physiological Sciences Dissociation from albumin: A potentially rate-limiting step in the clearance of substances by the liver (drug binding/organic
More information